✦ LIBER ✦

Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia

✍ Scribed by O'Malley, Dennis P; Orazi, Attilio; Wang, Mingsheng; Cheng, Liang

Book ID: 109888309
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 318 KB
Volume: 18
Category: Article
ISSN: 0893-3952
DOI: 10.1038/modpathol.3800481

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loss of heterozygosity identifies geneti

Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia

✍ O'Malley, Dennis P; Orazi, Attilio; Dunphy, Cherie H; Coleman, Benjamin R; Marks 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Frequent loss of heterozygosity without

Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype

✍ Tatiana Alessandra Gorletta; Patrizia Gasparini; Mario Milco D'Elios; Maurizio T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Abstract We performed a whole‐genome loss of heterozygosity (LOH) analysis of 32 cases of acute myeloid leukemia with normal karyotype using high‐density single nucleotide polymorphism arrays. LOH was found in 20% of cases. We identified two types of LOH: (i) interstitial, characterized by small

Analysis of X chromosome inactivation in

Analysis of X chromosome inactivation in autism spectrum disorders

✍ Xiaohong Gong; Elena Bacchelli; Francesca Blasi; Claudio Toma; Catalina Betancur 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract Autism spectrum disorders (ASD) are complex genetic disorders more frequently observed in males. Skewed X chromosome inactivation (XCI) is observed in heterozygous females carrying gene mutations involved in several X‐linked syndromes. In this study, we aimed to estimate the role of X‐l

Clonal relationships between epidermotro

Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis

✍ Bahrami, Soon; Cheng, Liang; Wang, Mingsheng; Jones, Timothy D; Malone, Janine C 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 414 KB

Cytogenetic findings in adult acute leuk

Cytogenetic findings in adult acute leukemia and myeloproliferative disorders with an involvement of megakaryocyte lineage

✍ Kazuma Ohyashiki; J. H. Ohyashiki; H. Hojo; M. Ohtaka; K. Toyama; K. Sugita; S. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 859 KB

Results of imatinib mesylate therapy in

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders

✍ Jorge Cortes; Francis Giles; Susan O'Brien; Deborah Thomas; Maher Albitar; Mary 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## BACKGROUND Imatinib mesylate is a selective tyrosine kinase inhibitor of c‐abl, bcr/abl, c‐kit, and platelet‐derived growth factor‐receptor (PDGF‐R). c‐kit is expressed in most patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) and PDGF has been implicated